SXTC - China SXT Pharmaceuticals Inc
IEX Last Trade
0.621
-0.069 -11.111%
Share volume: 256,117
Last Updated: Fri 30 Aug 2024 08:28:28 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$0.69
-0.07
-10.00%
Summary score
31%
Profitability
27%
Dept financing
21%
Liquidity
45%
Performance
35%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2014 - 2018
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
5.54%
Return on assets
3.92%
Return on sales
20.94%
Return on invested capital
-6.46%
Total debt ratio
57.09%
Debt ratio change over timeo
0%
Current Ratio
1.4%
Quick Ratio
1.05%
Cash Position Ratio
0%
Short-term ratios 2017 - 2018
The data are presented for the financials results of the quarters of the last year.
Return on equity
5.54%
Return on assets
3.92%
Return on sales
20.94%
Return on invested capital
-6.46%
Total debt ratio
57.09%
Debt ratio change over timeo
0%
Current Ratio
1.4%
Quick Ratio
1.05%
Cash Position Ratio
0%
Last quarter ratios 2018
The data are presented for the financials results of the last quarter.
Return on equity
5.54%
Return on assets
3.92%
Return on sales
20.94%
Return on invested capital
-6.46%
Total debt ratio
57.09%
Debt ratio change over time
0%
Current Ratio
1.4%
Quick Ratio
1.05%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 2014 - 2018
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | SXTC | LLY | NVO | JNJ |
---|---|---|---|---|
Return on equity | 5.54% | 2.1% | 21.33% | 2.44% |
Return on assets | 3.92% | 2.93% | 12.39% | 3.38% |
Return on sales | 20.94% | 21.3% | 42.63% | 26.79% |
Return on invested capital | -6.46% | 2.05% | -427.42% | 3.53% |
Profitability | 27% | 35% | 75% | 50% |
Total debt ratio | 57.09% | 65.37% | 52.87% | 53.79% |
Debt ratio change over time | 0% | -7.48% | -1.38% | 8.36% |
Dept financing | 22% | 25% | 20% | 46% |
Current Ratio | 1.4% | 1.37% | 1.25% | 1.41% |
Quick Ratio | 1.05% | 1.01% | 0.91% | 1.1% |
Cash Position Ratio | 0% | 0.32% | 0.39% | 0.52% |
Liquididy | 35% | 48% | 46% | 75% |
Short-term ratios | SXTC | LLY | NVO | JNJ |
---|---|---|---|---|
Return on equity | 5.54% | 1.24% | 20.27% | -0.12% |
Return on assets | 3.92% | 3.04% | 11.81% | 3.13% |
Return on sales | 20.94% | 22.59% | 42.51% | 24.83% |
Return on invested capital | -6.46% | 1.04% | -658.79% | 0.33% |
Profitability | 27% | 46% | 75% | 29% |
Total debt ratio | 57.09% | 68.11% | 51.64% | 56.69% |
Debt ratio change over time | 0% | -16.58% | -1.33% | 9.78% |
Dept financing | 21% | 25% | 19% | 46% |
Current Ratio | 1.4% | 1.37% | 1.25% | 1.41% |
Quick Ratio | 1.05% | 1.01% | 0.91% | 1.1% |
Cash Position Ratio | 0% | 0.32% | 0.39% | 0.52% |
Liquididy | 49% | 63% | 62% | 75% |